Postdoctoral Fellow (FDA)

As a postdoc in our lab, your research will advance our understanding of how both intrinsic and environmental factors affect induced pluripotent stem cell (iPSC) maintenance and differentiation. Prospective candidates will have the opportunity to employ state-of-the-art cell engineering techniques to develop novel cellular models and hematopoietic differentiation methods for evaluating the safety and efficacy of cell and gene therapies. Additionally, candidates will utilize molecular biology techniques to identify biomarkers and investigate heterogeneity and the consistency of the differentiation process throughout various stem cell-derived cellular products.

This appointment will initially be for one year, but may be renewed upon FDA recommendation and the availability of funds.

Qualified candidate will have received a doctoral degree in molecular & cell biology, genetics, immunology, bioengineering, or other related disciplines. The degree must have been received within 5 years of the appointment start date.

Preferably, candidates will have:

• Demonstrated proficiency with pluripotent stem cells (ESCs and/or iPSCs).
• Familiarity with hematopoietic differentiation, as supported by primary authorship in peer-reviewed journal(s).
• Experience in genetic modification methods such as programmable genome editing.
• Excellent organizational skills.
• Proficiency with standard molecular biology methods including, but not limited to, cell culture, transfections, molecular cloning, immunoassays, flow cytometry and quantitative real-time PCR.
• Familiarity with high throughput sequencing.
• Creativity, self-motivation, and the ability to assimilate new information from multiple sources.

U.S. citizens and permanent residents are eligible to apply. HHS welcomes foreign nationals with the exception of individuals from this list.